Company intelligence / Profile preview
Percheron Therapeutics Ltd
Melbourne (Toorak), Victoria, Australiaantisense.com.au ↗
- Ownership
- Private
- Employees
- ~9
- Development stage
- Other
01
Overview
The company's lead candidate ATL1102 has shown positive efficacy in a Phase IIa trial for DMD and is currently in an international Phase IIb trial. ATL1103 has completed Phase II trials for acromegaly, showing significant reduction in IGF-1 levels[4].
- Therapeutic areas
- DermatologyEndocrinologyRare DiseasesNeurology
- Modalities
- Antisense oligonucleotides
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Ionis Pharmaceuticals Inc. (formerly Isis Pharmaceuticals)
Beyond the preview
Go deeper on Percheron Therapeutics Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Percheron Therapeutics Ltd.